Aberdeen Group’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$49.7M Buy
92,637
+2,506
+3% +$1.34M 0.08% 206
2025
Q1
$37.4M Sell
90,131
-152,528
-63% -$63.3M 0.07% 234
2024
Q4
$100M Sell
242,659
-16,038
-6% -$6.61M 0.19% 110
2024
Q3
$131M Sell
258,697
-2,112
-0.8% -$1.07M 0.24% 95
2024
Q2
$127M Buy
260,809
+5,334
+2% +$2.6M 0.24% 89
2024
Q1
$138M Buy
255,475
+9,345
+4% +$5.05M 0.27% 79
2023
Q4
$137M Buy
246,130
+78,166
+47% +$43.4M 0.3% 74
2023
Q3
$73.4M Buy
167,964
+69,343
+70% +$30.3M 0.19% 112
2023
Q2
$49.5M Buy
98,621
+8,458
+9% +$4.25M 0.12% 171
2023
Q1
$45.1M Buy
90,163
+8,023
+10% +$4.01M 0.11% 187
2022
Q4
$33.5M Buy
82,140
+5,707
+7% +$2.33M 0.09% 244
2022
Q3
$24.9M Buy
76,433
+33,407
+78% +$10.9M 0.07% 280
2022
Q2
$15.1M Sell
43,026
-643
-1% -$226K 0.05% 345
2022
Q1
$24.1M Buy
43,669
+725
+2% +$400K 0.06% 276
2021
Q4
$28.3M Sell
42,944
-968
-2% -$637K 0.06% 278
2021
Q3
$27.6M Buy
43,912
+8,741
+25% +$5.5M 0.06% 288
2021
Q2
$22.2M Sell
35,171
-34,454
-49% -$21.8M 0.05% 339
2021
Q1
$34.1M Buy
69,625
+34,579
+99% +$16.9M 0.08% 243
2020
Q4
$17.5M Buy
35,046
+714
+2% +$357K 0.04% 346
2020
Q3
$13.5M Buy
34,332
+2,283
+7% +$897K 0.04% 363
2020
Q2
$10.6M Sell
32,049
-1,627
-5% -$537K 0.03% 402
2020
Q1
$8.17M Buy
33,676
+879
+3% +$213K 0.03% 420
2019
Q4
$8.56M Sell
32,797
-748
-2% -$195K 0.02% 488
2019
Q3
$9.12M Sell
33,545
-371
-1% -$101K 0.02% 460
2019
Q2
$9.34M Sell
33,916
-742
-2% -$204K 0.02% 522
2019
Q1
$7.75M Buy
34,658
+9,732
+39% +$2.18M 0.02% 552
2018
Q4
$4.68M Sell
24,926
-586
-2% -$110K 0.01% 580
2018
Q3
$6.37M Buy
25,512
+2,449
+11% +$611K 0.01% 575
2018
Q2
$5.03M Buy
23,063
+7,605
+49% +$1.66M 0.01% 598
2018
Q1
$2.96M Sell
15,458
-308
-2% -$59K 0.01% 621
2017
Q4
$2.47M Buy
15,766
+193
+1% +$30.2K ﹤0.01% 644
2017
Q3
$2.42M Buy
+15,573
New +$2.42M ﹤0.01% 628